Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability

por Mirza, Sameer, Katafiasz, Bryan J., Kumar, Rakesh, Wang, Jun, Mohibi, Shakur, Jain, Smrati, Gurumurthy, Channabasavaiah Basavaraju, Pandita, Tej K., Dave, Bhavana J., Band, Hamid, Band, Vimla
Publicado 2012

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

por Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
Publicado 2013

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

por Zhao, Xiangshan, Mirza, Sameer, Alshareeda, Alaa, Zhang, Ying, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Kim, Jun Hyun, Mohibi, Shakur, Goswami, Monica, Lele, Subodh M., West, William, Qiu, Fang, Ellis, Ian O., Rakha, Emad A., Green, Andrew R., Band, Hamid, Band, Vimla
Publicado 2012